Balyasny Asset Management LLC Soma Logic, Inc. Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.76 - $2.83 $4.36 Million - $7.01 Million	2,477,172 Added 16329.41%	2,492,342 $6.31 Million
Q3 2023 Nov 14, 2023	BUY	$1.99 - $2.45 $30,188 - $37,166	15,170 New	15,170 $36,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $5.47 $232,413 - $2.02 Million	-368,911 Reduced 38.36%	592,794 $1.72 Million
Q2 2022 Aug 15, 2022	BUY	$4.27 - $8.26 $3.77 Million - $7.29 Million	882,393 Added 1112.56%	961,705 $4.35 Million
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $438,127 - $720,091	61,970 Added 357.34%	79,312 $636,000

Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $181,917 - $247,643	17,342 New	17,342 $202,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.